Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein

S Bates1, D Parry, L Bonetta

  • 1Imperial Cancer Research Fund Laboratories, London, UK.

Oncogene
|June 1, 1994
PubMed

Insights

Functional retinoblastoma protein (pRb) is essential for the formation and stability of cyclin D-cyclin-dependent kinase complexes in human cells. These complexes regulate cell division and are disrupted in tumors with altered pRb or viral oncoproteins.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cyclins D1, D2, and D3 are key regulators of the G1 phase in the cell division cycle.
  • D-type cyclins associate with cyclin-dependent kinases (CDKs) 4 and 6, forming multiple functional complexes.

Purpose of the Study:

  • To investigate cell type-specific requirements for cyclin D-CDK complexes.
  • To determine alterations in these complexes in tumors with perturbed D-cyclin expression.

Main Methods:

  • Surveyed a series of tumor cell lines.
  • Compared tumor cell lines to non-tumorigenic counterparts.
  • Assessed the presence of cyclin D-CDK complexes.

Main Results:

  • Cyclin D-CDK4/6 complexes were detected in many cell lines.
  • No complexes were observed in human cells with DNA tumor virus oncoproteins.
  • Complexes were absent in cells with mutated or missing retinoblastoma protein (pRb).

Conclusions:

  • Functional pRb is crucial for the formation or stability of cyclin D-CDK complexes in human cells.
  • pRb acts not only as a substrate but also as a facilitator for these complexes.
  • Disruption of pRb or presence of viral oncoproteins impairs complex formation, impacting cell cycle regulation.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...